|
|
Article: RELIEF AT A PRICE HEALTH-CARE COSTS ARE RACING OUT OF CONTROL, AND THE COST OF PRESCRIPTION DRUGS IS NOTHING TO SNEEZE AT
- Article from:
- The Boston Globe (Boston, MA)
- Article date:
- June 25, 1989
- Author:
CopyrightCopyright (null) The Boston Globe. Provided by ProQuest LLC. (Hide copyright information)
|
This is the second in a series of occasional articles.
PLEASE SEE MICROFILM FOR CHART.
For years, hay fever sufferers faced a painful tradeoff: if they
wanted to stop their noses from running and their eyes from
itching, they had to put up with drowsiness, a side effect of all
the antihistamines on the market.
Seldane changed all that. Introduced in 1985, the new drug
offered the same relief as the existing products without the
sedation. It wasn't a cure for cancer, but for people with
allergies it was no small achievement.
Backed by an aggressive marketing campaign from its creator,
Merrell-Dow, Seldane took off faster than pollen on a windy day.
Last year $334 million ...